Filter
665
Filtered Results: 665
Text search:
nucleic
Acid
Featured
Recommendations
116
New Publications
157
Language
Document type
No document type
309
Guidelines
175
Studies & Reports
88
Manuals
53
Fact sheets
19
Strategic & Response Plan
7
Training Material
6
Situation Updates
4
Infographics
2
Resource Platforms
1
Videos
1
Countries / Regions
India
42
Global
22
Western and Central Europe
19
Tanzania
12
South Africa
11
Eastern Europe
11
Africa
10
Latin America and the Carribbean
10
Ethiopia
9
Brazil
8
Nigeria
7
Nepal
6
Kenya
6
Liberia
6
Rwanda
5
Peru
5
East and Southern Africa
5
Bangladesh
5
Zambia
5
Myanmar / Burma
5
Ukraine
4
Asia
4
Congo, Democratic Republic of
4
West and Central Africa
4
Eastern Europe and Central Asia
4
Russia
4
Namibia
4
Angola
4
Colombia
3
El Salvador
3
Sierra Leone
3
Senegal
3
Germany
3
Argentina
3
Uganda
3
China
2
Cameroon
2
Syria
2
Philippines
2
Guinea
2
Mozambique
2
Middle East and North Africa
2
South–East Asia Region
2
Portugal
2
Vietnam
2
Pakistan
2
Timor Leste/ East Timor
1
Lesotho
1
Turkey
1
Ghana
1
Burkina Faso
1
Afghanistan
1
Italy
1
USA
1
Haiti
1
Cambodia
1
Western Pacific Region
1
Uruguay
1
France
1
United Kingdom
1
Spain
1
Côte d’Ivoire / Ivory Coast
1
Moldova
1
Sri Lanka
1
Georgia
1
Chad
1
Bhutan
1
Botswana
1
South Sudan
1
Indonesia
1
Authors & Publishers
Publication Years
Category
Countries
165
Clinical Guidelines
114
Pharmacy & Technologies
46
Public Health
19
Key Resources
17
Women & Child Health
15
Capacity Building
5
Toolboxes
TB
131
COVID-19
112
HIV
80
NTDs
55
Rapid Response
29
Ebola & Marburg
25
Zika
18
AMR
15
2.0 Rapid Response
14
Refugee
13
Pharmacy
12
Malaria
12
Polio
6
Mental Health
5
Specific Hazards
4
Caregiver
4
Planetary Health
4
NCDs
3
Conflict
3
Natural Hazards
2
Health Financing Toolbox
2
Global Health Education
1
Scientific Brief, 17 June 2020
Each year since 2007, G-FINDER has provided policy-makers, donors, researchers and industry with a comprehensive analysis of global investment into research and development of new products to
prevent, diagnose, control or cure neglected diseases in low- and middle-income countries, making it the go...
WHO guidelines on meningitis diagnosis, treatment and care. Web Annex A. Quantitative evidence reports
recommended
The guidelines are primarily intended for health-care professionals working in first- or second-level health-care facilities, including emergency, inpatient and outpatient services. They are also directed at policy-makers, health-care planners and programme managers, academic institutions, non-gover...
WHO guidelines on meningitis diagnosis, treatment and care. Web Annex C. Evidence-to-Decision frameworks
recommended
The guidelines are primarily intended for health-care professionals working in first- or second-level health-care facilities, including emergency, inpatient and outpatient services. They are also directed at policy-makers, health-care planners and programme managers, academic institutions, non-gover...
2nd edition. The purpose of this document is to present updated standardized protocols that P. falciparum-endemic countries can use to determine the prevalence of parasites with pfhrp2/3 gene deletions causing negative HRP2 RDT results among symptomatic falciparum patients. The findings should be us...
Clinical Pharmacology: Advances and Applications, 2025:17 29–47
The framework recommends expanded coverage of malaria diagnostic and treatment services, intensified vector control to drive down transmission, strengthened malaria surveillance, and increased transborder collaboration, especially in terms of efforts to control the sale and use of artemisinin monoth...
Le Infezioni in Medicina, n. 1, 3-10, 2019
Offering additional pre-exposure prophylaxis (PrEP) choices has the potential to increase uptake and effective use of PrEP, and of HIV prevention overall, as it allows people to choose a method that they prefer.
In this guideline, WHO recommends an offering long-acting injectable lenacapavir (LEN...
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex B
This publication provides guidance for planning country-specific programming to achieve the triple elimination of mother-to-child (or vertical) transmission of HIV, syphilis and hepatitis B virus. It is based on the WHO Triple Elimination Framework, which promotes an integrated, person-centred appro...
WHO guidelines for clinical management of arboviral diseases: dengue, chikungunya, Zika and yellow fever
recommended
The new WHO guidelines provide clinical management recommendations for four of the most widespread arboviruses affecting humans: dengue, chikungunya, Zika, and yellow fever.
An integrated approach is vital, as these four diseases often present with similar symptoms, especially in the early stages...
Despite being a preventable and curable infectious disease, tuberculosis (TB) has continued to elude global controll efforts. In 2023, 8.2 milion people with TB were diagnosed and notified to the WHO, the hightest number ever reported since WHO began tracking.
On 13 August 2024, the Africa Centres for Disease Control (Africa CDC) declared the multi-country mpox outbreak a public health emergency of continental security, with strong recommendations to improve surveillance and vaccine deployment in all AU Member States. On 14 August 2024, the WHO Director-G...
Addressing TB comorbidities and risk factors is central to the World Health Organization (WHO) End TB Strategy. These guidelines consolidate the latest WHO recommendations on TB and key comorbidities. The guidelines are a living document and will include dedicated sections for each key TB comorbidit...
In an era of constrained resources and tightening budgets, strategic prioritization in tuberculosis (TB) programming is more critical than ever. Countries must make informed decisions to allocate limited resources effectively - maximizing impact, preventing avoidable deaths, and sustaining progress ...
Assecced: 03.09.2019
The systematic surveillance of antibiotic use and antibiotic re-sistance prevalence in humans and animals is imperative for managingbacterial infectious disease (JPIAMR, 2019;WHO, 2015). Many low-income countries currently face substantial challenges in building national surveillance systems due to ...
International Journal of Infectious Diseases 32 (2015) 111–117
